Get startedLog in
    Picture of Sprint Bioscience AB logo

    SPRINT — Sprint Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program

    Picture of Sprint Bioscience AB logoSprint Bioscience AB
    17/03/2026 07:11
    March 17 (Reuters) - Sprint Bioscience AB SPRINT.ST:

REPORTS POSITIVE RESULTS FROM THE VRK1 PROGRAM

VRK1 INHIBITION SELECTIVELY KILLS VRK2-LOW GLIOBLASTOMA CELLS

CELLS WITH NORMAL VRK2 LEVELS ARE NOT AFFECTED

SAYS THIS CONFIRMS THE TUMOR‐SPECIFIC MECHANISM OF THE PROGRAM

SIGNIFICANT TUMOR GROWTH INHIBITION OBSERVED WITH VRK1 INHIBITOR OVER 21 DAYS

Source text: ID:nMFNbQ48yd

Further company coverage: SPRINT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sprint Bioscience AB

    See all news